ChemicalBook--->CAS DataBase List--->130905-04-3

130905-04-3

130905-04-3 Structure

130905-04-3 Structure
IdentificationBack Directory
[Name]

phendioxan
[CAS]

130905-04-3
[Synonyms]

phendioxan
(2R)-2,3-Dihydro-3β-[[2-(2,6-dimethoxyphenoxy)ethylamino]methyl]-2α-phenyl-1,4-benzodioxin
1,4-Benzodioxin-2-methanamine, N-[2-(2,6-dimethoxyphenoxy)ethyl]-2,3-dihydro-3-phenyl-, (2R,3R)-rel-
[Molecular Formula]

C25H27NO5
[MDL Number]

MFCD00897723
[MOL File]

130905-04-3.mol
[Molecular Weight]

421.49
Chemical PropertiesBack Directory
[Boiling point ]

559.0±50.0 °C(Predicted)
[density ]

1.164±0.06 g/cm3(Predicted)
[pka]

7.61±0.20(Predicted)
Hazard InformationBack Directory
[Uses]

Phendioxan is a compound with binding activity at the α(1)-adrenaline receptor subtype. The facilitated membrane diffusion of phendioxan is thought to be associated with improved α(1d)-AR affinity. Docking simulations of phendioxan at biological targets supported the stoichiometric analysis and revealed the importance of polar, electrostatic, hydrophobic, and shape effects of its phenoxy terminal orthogonal substituents on ligand binding[1].
[References]

[1] Structure-activity relationships in 1,4-benzodioxan-related compounds. 10. Novel α1-adrenoreceptor antagonists related to openphendioxan: synthesis, biological evaluation, and α1d computational study
130905-04-3 suppliers list
Tags:130905-04-3 Related Product Information

  • HomePage | Member Companies | Advertising | Contact us | Previous WebSite | MSDS | CAS Index | CAS DataBase | Privacy | Terms | About Us
  • All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.
    According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.
  • Copyright © 2023 ChemicalBook All rights reserved.